US7030221B2ExpiredUtilityA1

AMPA-binding human GluR3 receptors

Assignee: NPS ALLELIX CORPPriority: Jun 10, 1992Filed: May 21, 2002Granted: Apr 18, 2006
Est. expiryJun 10, 2012(expired)· nominal 20-yr term from priority
C07K 14/705C07K 14/70571
61
PatentIndex Score
0
Cited by
19
References
5
Claims

Abstract

Described herein are isolated polynucleotides which code for a family of AMPA-type human CNS receptors. The receptors are characterized structurally and the construction and use of cell lines expressing these receptors are disclosed.

Claims

exact text as granted — not AI-modified
1. A human GluR3A receptor subunit or a human GluR3B receptor subunit, wherein the GluR3A receptor subunit and the GluR3B receptor subunit are in a form essentially free from other proteins of human origin. 
     
     
       2. The human GluR3A receptor subunit according to  claim 1 . 
     
     
       3. The human GluR3B receptor subunit according to  claim 1 . 
     
     
       4. An immunogenic fragment of a human GluR3B receptor subunit, wherein the immunogenic fragment is selected from the group consisting of residues 178–193, residues 479–522, residues 594–603, and residues 817–866. 
     
     
       5. An immunogenic fragment of a human GluR3A receptor subunit, wherein the immunogenic fragment is selected from the group consisting of residues 178–193, residues 479–522, residues 594–603 and residues 817–866.

Join the waitlist — get patent alerts

Track US7030221B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.